The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims.
The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR.
Tennessee-based Xsolis said the incident occurred in January, and the sensitive data was from its clients. The company provides AI-powered case management software to hospitals and health insurers.
As the Medicare drug price negotiation program enters its fourth year next year, regulators are looking to put a set of guidelines in place that make it clear how medications are selected for inclusion and what the deliberation process will look like for biopharma companies.
Coming in at just 0.04 mmol gadolinium per kilogram body weight, gadoquatrane has 60% less gadolinium than the lowest dose GBCA currently on the market.
The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
